{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tirapazamine",
  "nciThesaurus": {
    "casRegistry": "27314-97-2",
    "chebiId": "",
    "chemicalFormula": "C7H6N4O2",
    "definition": "A benzotriazine di-N-oxide with potential antineoplastic activity.  Tirapazamine is selectively activated by multiple reductases to form free radicals in hypoxic cells, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death.  This agent also sensitizes hypoxic cells to ionizing radiation and inhibits the repair of radiation-induced DNA strand breaks via inhibition of topoisomerase II.",
    "fdaUniiCode": "1UD32YR59G",
    "identifier": "C1464",
    "preferredName": "Tirapazamine",
    "semanticType": "Organic Chemical",
    "subclassOf": [],
    "synonyms": [
      "3-Amino-1,2,4-benzotriazine-1,4-dioxide",
      "SR 4233",
      "SR4233",
      "TIRAPAZAMINE",
      "Tirapazamine",
      "Tirazone",
      "WIN 59075",
      "tirapazamine"
    ]
  }
}